Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cannapharmarx Inc (OP: CPMD ) 0.0082 -0.0001 (-1.20%) Streaming Delayed Price Updated: 1:17 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 105,000 Open 0.0075 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0083 Today's Range 0.0065 - 0.0082 52wk Range 0.0001 - 0.0279 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product August 15, 2024 Via ACCESSWIRE Q1 2024 Financial Results June 27, 2024 Via ACCESSWIRE Performance YTD +530.77% +530.77% 1 Month +17.14% +17.14% 3 Month -25.45% -25.45% 6 Month -51.76% -51.76% 1 Year +2.50% +2.50% More News Read More CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call May 20, 2024 Via ACCESSWIRE CannaPharmaRx to Host Investor Conference Call May 20, 2024 Via ACCESSWIRE CannapharmaRx Pays Off Convertible Notes April 02, 2024 Via ACCESSWIRE CannapharmaRx Receives First Purchase Order and Begins Shipment of Product March 14, 2024 Via ACCESSWIRE CannaPharmaRx Completes First Harvests March 12, 2024 Via ACCESSWIRE CannaPharmaRx CEO Provides Annual Update Message February 15, 2024 Via ACCESSWIRE CannaPharmaRx to Hold Investor Conference Call March 07, 2024 Via ACCESSWIRE Cannapharmarx Partners With ICAN To Expand Cannabis Distribution In Latin America March 05, 2024 Via Benzinga Topics Cannabis Exposures Cannabis CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas March 05, 2024 Via ACCESSWIRE CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration February 23, 2024 Via ACCESSWIRE CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek February 16, 2024 Via ACCESSWIRE Cannabis Industry Changes As Marijuana Rescheduling Looms September 15, 2023 Via Benzinga Topics Cannabis Exposures Cannabis CannaPharmaRx Expands Board of Directors August 25, 2023 Via ACCESSWIRE Cannabis Movers & Shakers: Delaware's New Marijuana Commissioner And Latest Industry Appointments June 23, 2023 Via Benzinga CannaPharmaRx Appoints Dean Medwid as New CEO June 23, 2023 Via ACCESSWIRE CannaPharmaRx Signs Agreement with Nasha Genetics April 19, 2023 Via ACCESSWIRE CannaPharmaRx Signs Supply Agreement With Y.S.A For Up To $15M Annually Of Commercial Cannabis March 30, 2023 Via Benzinga CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis March 30, 2023 Via ACCESSWIRE New Leaf Ventures Enters Into Genetics Supply Agreement With CannaPharmaRX March 21, 2023 Via Benzinga CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website March 21, 2023 Via ACCESSWIRE CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company February 21, 2023 Via ACCESSWIRE CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock February 01, 2023 Via ACCESSWIRE CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023 January 30, 2023 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
